SIG990 Preclinical

[lws1]

Check out this Preclinical from Signum (Spun off to Arglye). The change in skin color is amazing. Also it says it inhibits LL-37 induced inflammation. I believe this is in line with Galo's research.

http://argyletherapeutics.com/docume...ster-FINAL.pdf

I wonder when the Phase 1 will start.

[DukeCity]

Great find lws1,
Looks like SIG990 still is many years away, but it gives hope for the future. Remember "V-101"? Now owned by Allergan, they aquired it when they bought out Vicepts, still in Phase 2 Trials as of today. So there are a few very promising topicals coming out eventually, hopefully starting with Sansrosa.

[DukeCity]

Spun off again to Brickell Biotech last month..